03.10.2012
- Drugmakers Sanofi and Bristol-Myers Squibb plan to revamp their 15-year-old alliance from Jan. 1 in response to lost exclusivity on two key drugs and the arrival of generic...
25.09.2012
- Market Transition - When we think about the patent cliff, an image along the lines of a massive waterfall, with companies' revenues in free fall comes to mind. What we usually...
25.09.2012
- Life-sciences and health investing, long shunned by venture-capital investors, is making a comeback. Several venture firms globally have each raised or are raising funds this year...
21.09.2012
- Syngenta, the world's No.1 agrobusiness company, is buying Belgian seed firm Devgen for €403 million ($522 million), paying a hefty premium to boost its position in rice and close...
18.09.2012
- Johnson & Johnson is stepping a drive to tap into emerging healthcare technology by establishing new innovation centres in four of the world's biotech hot spots - California...
18.09.2012
- Billionaire German investor Dietmar Hopp is betting another €80 million ($105 million) on CureVac, a pioneer of vaccines based on a molecule related to DNA, in one of the biggest...
16.09.2012
- A U.S. farmer group on Tuesday dropped its opposition to efforts by Dow AgroSciences to roll out a new biotech crop system in exchange for some concessions by Dow, including help...
04.09.2012
- Israeli biotechnology firm Atox Bio, developing a drug it hopes can treat severe infections such as those caused by flesh-eating bacteria and deadly viruses, expects to ask...
31.08.2012
- Hovione announced the appointment of Dr. Mike Ironside as General Manager, TTC in New Jersey. Dr. Ironside was previously with GSK in the UK and with AMRI and most recently with...
30.08.2012
- U.S. drug regulators gave the nod to a Teva Pharmaceutical Industries drug that boosts the production of infection-fighting white blood cells in certain cancer patients receiving...
